Advertisement
Advertisement

QNTM

QNTM logo

Quantum Biopharma Ltd. Class B Subordinate Voting Shares

3.91
USD
Sponsored
+0.06
+1.56%
Jun 24, 16:00 UTC -4
Closed
exchange

After-Market

4.00

+0.09
+2.40%

QNTM Earnings Reports

Positive Surprise Ratio

QNTM beat 2 of 5 last estimates.

40%

Next Report

Date of Next Report
Aug 04, 2026
Estimate for Q2 26 (Revenue/ EPS)
--
/
--
Implied change from Q1 26 (Revenue/ EPS)
--
/
--
Implied change from Q2 25 (Revenue/ EPS)
--
/
--

Quantum Biopharma Ltd. Class B Subordinate Voting Shares earnings per share and revenue

On May 12, 2026, QNTM reported earnings of -- USD per share (EPS) for Q1 26, -- the estimate of -- USD, resulting in a --% surprise. Revenue reached --, compared to an expected --, with a --% difference.
Looking ahead to Q2 26, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Vistagen Therapeutics, Inc. Common Stock
Report Date
Jun 15, 2026 For Q4 26
Estimate
-$0.34
Actual
-$0.37
Surprise
-7.75%
logo
enGene Therapeutics Inc. Common Stock
Report Date
Jun 15, 2026 For Q2 26
Estimate
-$0.47
Actual
-$0.43
Surprise
+10.32%
logo
Grace Therapeutics, Inc. Common Stock
Report Date
Jun 18, 2026 For Q4 26
Estimate
-$0.23
Actual
-$0.06
Surprise
+74.42%
FAQ
For Q1 2026, Quantum Biopharma Ltd. Class B Subordinate Voting Shares reported EPS of --, missing estimates by --, and revenue of --, -- -- expectations.
The stock price moved -- --, changed from -- before the earnings release to -- the day after.
The next earning report is scheduled for Aug 04, 2026.
Based on -- analysts, Quantum Biopharma Ltd. Class B Subordinate Voting Shares is expected to report EPS of -- and revenue of -- for Q2 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement